Shilpa Medicare (SHILPAMED)
FAST GROWERFairStock Score: 33/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹427.6 |
| Market Cap | ₹6,584.26 Cr |
| P/E Ratio | 37.22 |
| ROCE | 7.82% |
| ROE | 2.31% |
| Dividend Yield | 0.15% |
| Profit Growth | 69.92% |
| Debt/Equity | 0.24 |
| Sales Growth | 28.32% |
| Promoter Holding | 40.13% |
| 52-Week Range | ₹259.5 — ₹581 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹134.92 |
Shilpa Medicare trades with a P/E ratio of 37.22, ROCE of 7.82%, ROE of 2.31%, profit growth of 69.92%, debt-to-equity of 0.24. The FairStock Score of 33/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer